Literature DB >> 15124994

Influence of iodine contrast agent on the range of ion beams for radiotherapy.

Hansjörg Wertz1, Oliver Jäkel.   

Abstract

The basis for the range calculation of heavy ions in tissue is an empirical correlation between x-ray CT numbers and ion ranges measured for tissue equivalent materials. Iodine contrast agents (CA), used during computed tomography (CT) imaging, lead to an increase of the Hounsfield units in tissue with increased CA uptake and cause errors in the calculation of the ranges. The aim of this work is to quantify how accurately ion range is calculated in CA loaded tissue. In order to quantify the mean change in Hounsfield units (HU), a statistical analysis of 25 CT data sets with and without CA was performed. To establish a relation between the change in Hounsfield units due to CA and changes in ion range, the Hounsfield number for various CA concentrations and the range of ions in CA was measured. The analysis of CT data sets showed that after intravenous injection of 100 ml contrast agent (Imeron300) at a concentration of 300 mg iodine/ml an increase of the Hounsfield numbers in tumor tissue of up to 57 HU can be observed. The measured range shift in CA is much smaller than calculated by the treatment planning system (TPS). The maximum error in range resulting from the CA enhanced data is approximately 2.5% and results mainly from this wrong interpretation of HU by the TPS. For a tumor with an extent of 5 cm this leads to an exaggeration of the ion ranges during irradiation of (1.24+/-0.04) mm. This may be clinically relevant in cases where highest precision is needed and where organs at risk are close to the target volume. In view of these findings it may be safer to rely solely on native CT data for the purpose of dose and range optimization in therapy planning for heavy ions and protons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15124994     DOI: 10.1118/1.1650871

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  9 in total

1.  Influence of the contrast agents on treatment planning dose calculations of prostate and rectal cancers.

Authors:  Sahel Heydarheydari; Negin Farshchian; Abbas Haghparast
Journal:  Rep Pract Oncol Radiother       Date:  2016-05-06

2.  Dosimetric study of Hounsfield number correction effect in areas influenced by contrast product in lungs case.

Authors:  Yassine Oulhouq; Dikra Bakari; Deae-Eddine Krim; Mustapha Zerfaoui; Abdeslem Rrhioua; Soufiane Berhili; Loubna Mezouar
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

3.  Effect of contrast medium on treatment modalities planned with different photon beam energies: a planning study.

Authors:  Manindra Bhushan; Deepak Tripathi; Girigesh Yadav; Lalit Kumar; Abhinav Dewan; Sarthak Tandon; Gourav Kumar; Inderjit Kaur Wahi; Munish Gairola
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

4.  Feasibility of using post-contrast dual-energy CT for pediatric radiation treatment planning and dose calculation.

Authors:  Ozgur Ates; Chia-Ho Hua; Li Zhao; Nadav Shapira; Yoad Yagil; Thomas E Merchant; Matthew Krasin
Journal:  Br J Radiol       Date:  2020-11-19       Impact factor: 3.039

5.  Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.

Authors:  Arthur Lalonde; Mislav Bobić; Brian Winey; Joost Verburg; Gregory C Sharp; Harald Paganetti
Journal:  Radiother Oncol       Date:  2021-03-17       Impact factor: 6.901

6.  Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams.

Authors:  H Immo Lehmann; Christian Graeff; Palma Simoniello; Anna Constantinescu; Mitsuru Takami; Patrick Lugenbiel; Daniel Richter; Anna Eichhorn; Matthias Prall; Robert Kaderka; Fine Fiedler; Stephan Helmbrecht; Claudia Fournier; Nadine Erbeldinger; Ann-Kathrin Rahm; Rasmus Rivinius; Dierk Thomas; Hugo A Katus; Susan B Johnson; Kay D Parker; Jürgen Debus; Samuel J Asirvatham; Christoph Bert; Marco Durante; Douglas L Packer
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

Review 7.  Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT.

Authors:  Matthijs Ferdinand Kruis
Journal:  J Appl Clin Med Phys       Date:  2021-11-07       Impact factor: 2.102

8.  Radiotherapy treatment planning with contrast-enhanced computed tomography: feasibility of dual-energy virtual unenhanced imaging for improved dose calculations.

Authors:  Sachiko Yamada; Takashi Ueguchi; Toshiyuki Ogata; Hirokazu Mizuno; Ryota Ogihara; Masahiko Koizumi; Takeshi Shimazu; Kenya Murase; Kazuhiko Ogawa
Journal:  Radiat Oncol       Date:  2014-07-29       Impact factor: 3.481

9.  Effect of contrast enhanced CT scans on heterogeneity corrected dose computations in the lung.

Authors:  Nichola A Burridge; Carl G Rowbottom; Paul A Burt
Journal:  J Appl Clin Med Phys       Date:  2006-11-28       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.